These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22072869)

  • 1. Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles.
    Chen Y; Wan Y; Wang Y; Zhang H; Jiao Z
    Int J Nanomedicine; 2011; 6():2321-6. PubMed ID: 22072869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daunorubicin-TiO2 nanocomposites as a "smart" pH-responsive drug delivery system.
    Zhang H; Wang C; Chen B; Wang X
    Int J Nanomedicine; 2012; 7():235-42. PubMed ID: 22275838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics.
    Deng Y; Zhang H
    Int J Nanomedicine; 2013; 8():1835-41. PubMed ID: 23674895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of initial anti-tumor effect via polydopamine modified doxorubicin-loaded electrospun fibrous membranes.
    Yuan Z; Zhao X; Wang X; Qiu W; Chen X; Zheng Q; Cui W
    Int J Clin Exp Pathol; 2014; 7(9):5436-49. PubMed ID: 25337186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titanium dioxide (TiO2) nanoparticles induce JB6 cell apoptosis through activation of the caspase-8/Bid and mitochondrial pathways.
    Zhao J; Bowman L; Zhang X; Vallyathan V; Young SH; Castranova V; Ding M
    J Toxicol Environ Health A; 2009; 72(19):1141-9. PubMed ID: 20077182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
    Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing anti-tumor efficacy of Doxorubicin by non-covalent conjugation to gold nanoparticles - in vitro studies on feline fibrosarcoma cell lines.
    Wójcik M; Lewandowski W; Król M; Pawłowski K; Mieczkowski J; Lechowski R; Zabielska K
    PLoS One; 2015; 10(4):e0124955. PubMed ID: 25928423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-loaded Fe
    Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
    J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted tetrahedral DNA nanostructures for doxorubicin delivery and enhancement of apoptosis.
    Yan J; Chen J; Zhang N; Yang Y; Zhu W; Li L; He B
    J Mater Chem B; 2020 Jan; 8(3):492-503. PubMed ID: 31840727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core-shell structured Fe3O4@TiO2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy of cancer.
    Shen S; Wu L; Liu J; Xie M; Shen H; Qi X; Yan Y; Ge Y; Jin Y
    Int J Pharm; 2015; 486(1-2):380-8. PubMed ID: 25841570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles.
    Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z
    Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles.
    Wang C; Zhang H; Chen B; Yin H; Wang W
    Int J Nanomedicine; 2011; 6():1929-35. PubMed ID: 21931488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porous NH
    Rengaraj A; Puthiaraj P; Heo NS; Lee H; Hwang SK; Kwon S; Ahn WS; Huh YS
    Colloids Surf B Biointerfaces; 2017 Dec; 160():1-10. PubMed ID: 28910676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies.
    Spadavecchia J; Movia D; Moore C; Maguire CM; Moustaoui H; Casale S; Volkov Y; Prina-Mello A
    Int J Nanomedicine; 2016; 11():791-822. PubMed ID: 27013874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of doxorubicin mediated by gold nanoparticles and resveratrol in two human cervical tumor cell lines.
    Tomoaia G; Horovitz O; Mocanu A; Nita A; Avram A; Racz CP; Soritau O; Cenariu M; Tomoaia-Cotisel M
    Colloids Surf B Biointerfaces; 2015 Nov; 135():726-734. PubMed ID: 26340362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Abo Mansour HE; El-Batsh MM; Badawy NS; Mehanna ET; Mesbah NM; Abo-Elmatty DM
    Hum Exp Toxicol; 2020 Nov; 39(11):1528-1544. PubMed ID: 32519553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake.
    Dong F; Dong X; Zhou L; Xiao H; Ho PY; Wong MS; Wang Y
    Colloids Surf B Biointerfaces; 2016 Apr; 140():324-331. PubMed ID: 26764113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of doxorubicin anticancer drug loading on different metal oxide nanoparticles.
    Javed KR; Ahmad M; Ali S; Butt MZ; Nafees M; Butt AR; Nadeem M; Shahid A
    Medicine (Baltimore); 2015 Mar; 94(11):e617. PubMed ID: 25789952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.